insights_auto
Why is DRUG up 2.74%?
Dive Deeperchevron_right
DRUG:CNSX
Bright Minds Biosciences Inc
CA$33.00
arrow_upward
+2.74%(+0.88) 1D
Nov 12, 4:00:00 PM GMT-5 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRUG...
Open
CA$32.18
High
CA$33.09
Low
CA$32.18
Mkt. cap
325.51M
Avg. vol.
566.00
Volume
1.29K
52-wk high
CA$170.00
52-wk low
CA$25.95
EPS
-CA$2.90
No. of employees
26
Open
CA$32.18
High
CA$33.09
Low
CA$32.18
Mkt. cap
325.51M
Avg. vol.
566.00
Volume
1.29K
52-wk high
CA$170.00
52-wk low
CA$25.95
EPS
-CA$2.90
No. of employees
26
News stories
From web sources and news partners
TV News Check
·
22 minutes ago
Dow Dips 189, Nasdaq Sinks 100, S&P 500 Falls 27
CNBC
·
1 hour ago
Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump: Live updates
The Wealth Advisor
·
48 minutes ago
Jeffrey Gundlach Wants Out of AI’s ‘Blast Radius.’ Even the S&P 500 Is Too Close.
Reuters
·
1 day ago
Stocks end higher as CoreWeave results ease AI spending worries
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc
CEO-
Employees26
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitebrightmindsbio.com